What is he best known for?
The fields of study he is best known for:
Yasuo Tsutsumi mostly deals with Immunology, Biophysics, In vivo, Biochemistry and Pharmacology.
Yasuo Tsutsumi interconnects Polyethylene glycol and Virology in the investigation of issues within Immunology.
His studies in Biophysics integrate themes in fields like Cell culture, Nanotechnology, Reactive oxygen species, DNA and Particle size.
His research in In vivo tackles topics such as In vitro which are related to areas like Viral vector.
He has researched Pharmacology in several fields, including Toxicity, Kidney and Drug delivery.
His Tumor necrosis factor alpha study combines topics in areas such as Receptor and Genetic transfer.
His most cited work include:
- Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. (476 citations)
- Amorphous nanosilica induce endocytosis-dependent ROS generation and DNA damage in human keratinocytes (261 citations)
- Site-specific PEGylation of a lysine-deficient TNF-α with full bioactivity (203 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, Molecular biology, Tumor necrosis factor alpha, In vivo and Biochemistry.
In his research, Cancer research is intimately related to Antibody, which falls under the overarching field of Molecular biology.
His work carried out in the field of Tumor necrosis factor alpha brings together such families of science as Inflammation, Receptor and Cytokine.
His In vivo research includes themes of In vitro, Potency, Polyethylene glycol and Pharmacology.
His Pharmacology research is multidisciplinary, relying on both Toxicity and Drug delivery.
His work in Immune system tackles topics such as Antigen which are related to areas like Cytotoxic T cell.
He most often published in these fields:
- Immunology (18.73%)
- Molecular biology (17.94%)
- Tumor necrosis factor alpha (16.36%)
What were the highlights of his more recent work (between 2013-2021)?
- Biophysics (12.14%)
- Cancer research (10.55%)
- Nanotechnology (10.29%)
In recent papers he was focusing on the following fields of study:
Yasuo Tsutsumi mainly investigates Biophysics, Cancer research, Nanotechnology, Nanoparticle and Silica nanoparticles.
The study incorporates disciplines such as In vitro, Surface modification, Stereochemistry, Toxicity and Silver nanoparticle in addition to Biophysics.
His biological study spans a wide range of topics, including Cancer, Breast cancer, Triple-negative breast cancer, Antibody and EPHA10.
His Antibody study combines topics in areas such as Molecular biology and Immune system.
The Nanoparticle study combines topics in areas such as Absorption and Particle size.
His research on Immunology frequently links to adjacent areas such as In vivo.
Between 2013 and 2021, his most popular works were:
- Clusterin in the protein corona plays a key role in the stealth effect of nanoparticles against phagocytes. (36 citations)
- Distribution of Silver Nanoparticles to Breast Milk and Their Biological Effects on Breast-Fed Offspring Mice (35 citations)
- Metal nanoparticles in the presence of lipopolysaccharides trigger the onset of metal allergy in mice (35 citations)
In his most recent research, the most cited papers focused on:
Yasuo Tsutsumi mainly focuses on Nanoparticle, Nanotechnology, Biophysics, Silver nanoparticle and Immune system.
His studies in Nanotechnology integrate themes in fields like Viability assay, Oxidative stress, Chromatography and Intracellular.
His work deals with themes such as Cell culture, Biochemistry, Particle size, Protein Corona and Nanomaterials, which intersect with Biophysics.
His Immune system research entails a greater understanding of Immunology.
In his work, EPHA10 is strongly intertwined with Antigen, which is a subfield of Antibody.
His B cell research is multidisciplinary, incorporating perspectives in Cancer research, In vitro and In vivo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
